NEW YORK (GenomeWeb News) – German biotech firm Protagen said today that it has sold its subsidiary Protagen Protein Services to venture capital fund Zukunftsfond Heilbronn.

The sale will provide Protagen with funds to support its diagnostic development efforts, the company said. Financial and other terms of the deal were not disclosed.

Spun out as a 100 percent subsidiary of Protagen in January 2012, Protagen Protein Services offers a variety of protein analysis services aimed at academic labs as well as biopharmaceutical and biosimilars work.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

The Wall Street Journal looks into the cost of new gene therapies.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.